Bladder Cancer Clinical Trial
Genetic Susceptibility to Bladder Cancer
Summary
This clinical research study will identify biologic and lifestyle factors which increase a person's risk of developing specific cancer. Researchers propose to conduct a case-control study examining interindividual differences in susceptibility to tobacco carcinogenesis as predictors of bladder cancer risk. We will measure susceptibility to tobacco carcinogenesis and this will include studies of the genetic modulation of carcinogen activation and detoxification and of chromosome sensitivity to tobacco mutagens.
Full Description
Researchers propose to conduct a case-control study examining interindividual differences in susceptibility to tobacco carcinogenesis as predictors of bladder cancer risk. We will measure susceptibility to tobacco carcinogenesis and this will include studies of the genetic modulation of carcinogen activation and detoxification and of chromosome sensitivity to tobacco mutagens.
Eligibility Criteria
Inclusion Criteria:
Subject has a histologically confirmed diagnosis of superficial or muscle-invasive bladder cancer
Subject is a Texas resident.
Subject can understand English or a qualified translator is available for the interview.
Subjects of any age, gender, or ethnicity are eligible to participate in the study.
Subject consents to participate in the study.
Exclusion Criteria:
Subject has had prior treatment with systemic chemotherapy or radiotherapy in the past 6 months.
Subject has been diagnosed with superficial or muscle-invasive bladder cancer more than twelve months ago.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Houston Texas, 77030, United States
How clear is this clinincal trial information?